Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2014.11.009PMID 25435253PMCID PMC4278362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and Biological Evaluation of 2,4-Diaminopyrimidine-Based Antifolate Drugs against Bacillus anthracis

  2014cited by this paper
• Comparative Study of the Frech Catalyst with Two Conventional Catalysts in the Heck Synthesis of 2,4-Diaminopyrimidine-based Antibiotics

  2013cited by this paper
• Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.

  2013cited by this paper
• Inhibition of Bacterial Dihydrofolate Reductase by 6‐Alkyl‐2,4‐diaminopyrimidines

  2012cited by this paper
• Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode.

  2012cited by this paper
• Catalysis and Sulfa Drug Resistance in Dihydropteroate Synthase

  2012cited by this paper
• Microwave-assisted Heck Synthesis of Substituted 2,4-Diaminopyrimidine-based Antibiotics

  2012cited by this paper
• Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.

  2012cited by this paper
• Approaches to Iodinated Derivatives of Vanillin and Isovanillin

  2012cited by this paper
• New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

  2011cited by this paper
• Antibiotic resistance is ancient

  2011cited by this paper
• Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.

  2011cited by this paper
• Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.

  2009cited by this paper
• In Vitro Activities of Three New Dihydrofolate Reductase Inhibitors against Clinical Isolates of Gram-Positive Bacteria

  2009cited by this paper
• X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.

  2009cited by this paper
• Crystal Structure of Bacillus anthracis Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and Selectivity

  2009cited by this paper
• Antistaphylococcal Activity of Dihydrophthalazine Antifolates, a Family of Novel Antibacterial Drugs

  2009cited by this paper
• In Vitro and In Vivo Properties of Dihydrophthalazine Antifolates, a Novel Family of Antibacterial Drugs

  2009cited by this paper
• Antistreptococcal Activity of AR-709 Compared to That of Other Agents

  2008cited by this paper
• In Vitro Efficacy of New Antifolates against Trimethoprim-Resistant Bacillus anthracis

  2007cited by this paper
• Structural characteristics of small-molecule antifolate compounds

  2006cited by this paper
• Functional Cloning of Bacillus anthracis Dihydrofolate Reductase and Confirmation of Natural Resistance to Trimethoprim

  2004cited by this paper
• The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park.

  1991cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

  1990cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Basically Substituted Aliphatic Nitriles and their Catalytic Reduction to Amines1

  1944cited by this paper

• A critical review on the sustainable synthesis of pyrimidine-based heterocycles and their biological activities

  2025cites this paper
• Discovery of new 2,4-diaminopyrimidines derivatives as EGFRT790M kinase inhibitors: a structure-based approach with DFT calculation, drug-likeness, ADME-toxicity properties evaluation and MD simulation

  2024cites this paper
• Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening

  2021cites this paper
• Inhibitor design to target a unique feature in the folate pocket of Staphylococcus aureus dihydrofolate reductase.

  2020cites this paper
• Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors

  2019cites this paper
• Trimethoprim: An Old Antibacterial Drug as a Template to Search for New Targets. Synthesis, Biological Activity and Molecular Modeling Study of Novel Trimethoprim Analogs

  2019cites this paper
• Recent Design and Structure-Activity Relationship Studies on Modifications of DHFR Inhibitors as Anticancer Agents.

  2019cites this paper
• Synthesis and evaluation of new 2,6-diamino-5-hetarylpyrimidines as inhibitors of dihydrofolate reductase

  2018cites this paper
• Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs

  2018cites this paper
• Perturbation of genome integrity to fight pathogenic microorganisms.

  2017cites this paper
• 5-HT7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity.

  2016cites this paper
• Evaluation of New Dihydrophthalazine-Appended 2,4-Diaminopyrimidines against Bacillus anthracis: Improved Syntheses Using a New Pincer Complex

  2015cites this paper